But why focus only on physicians? The authors mention that the US Food and Drug Administration (FDA) cannot, by statute, consider cost or cost-effectiveness when considering medications for approval. The FDA is an arm of our government and, as such, should not approve medications for uses for which there is no prospective randomized evidence of effectiveness. Time-limited exceptions can be made for compassionate use of drugs with great promise that are in the pipeline of appropriate testing. However, if a statute requires the FDA to approve useless medications they are then, by law, required to disserve both the health and the finances of the public. If so, the statute is broken and should be repaired.